UPCOMING CALLS FOR PUBLIC CONSULTATION

We will selectively include calls for public consultation from multilateral agencies, governments, INGOs and other sources where there is a clear intersection with consent/assent. This might be obvious from the title of the draft guidance, regulations, etc., but more often, it will be a thematic area or topic – if properly addressed at all. If you would like to explore participation with our working group developing submissions for these calls, please contact us [david.r.curry@ge2p2global.org].

Request for Information: Soliciting Input on Opportunities, Gaps, and Challenges in Global Health Research in Neurological Diseases and Stroke
Notice Number: NOT-NS-24-018 Response date: July 1, 2024
The National Institute Neurological Diseases and Stroke (NINDS) has released a Request for Information from all stakeholders to identify global health research priorities, capacity building and training needs, and best practices or strategies that could facilitate equitable global health research in neurological disorders. Information requested

This RFI is intended to help NINDS identify global health research priorities, capacity building and training needs, and best practices or strategies that could facilitate equitable global health research in neurological disorders. The NINDS invites input from all stakeholders, including researchers, health care providers, people with lived experience (e.g., patients with neurological conditions, family members, caregivers), patient advocates, health advocacy organizations, scientific or professional organizations, federal agencies, non-profit and private sector organizations, as well as other interested members of the public. Organizations may consider submitting a response on behalf of the organization or share this RFI link with its members.

Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity in Access Planning
Posted on May 21, 2024 Comments must be received by July 22, 2024
   NIH is proposing to develop and implement a new policy within the NIH’s Intramural Research Program, the internal research arm of the agency. The policy would require organizations partnering with NIH through a patent licensing agreement that succeed in bringing certain products to market to submit a plan outlining steps they intend to take to promote patient access to any resulting drug, biologic, vaccine, or device. NIH seeks input on this draft policy and accompanying draft license agreement language that incorporates patient access in the commercialization process for NIH-owned inventions.

NIH will use the responses to this request for information to develop a final policy. Comments on the proposed policy must be submitted at: https://osp.od.nih.gov/comment-form-draft-nih-intramuralresearch-program-policy-promoting-equity-through-access-planning.

In addition, NIH will be hosting an informational webinar on the proposed policy on June 11, 2024. More information on the agenda and how to register will be provided shortly.

For additional context on the benefits of access planning, please see NIH’s 2023 Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer. Questions may be sent to SciencePolicy@od.nih.gov.